Evidence map›Paper›PMID 36851623›Full record

ArticleViruses2023

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance.

Sheila F O'Brien, Cassandra N Reedman, Carla Osiowy, Shelly Bolotin, Qi-Long Yi, Lillian Lourenço, Antoine Lewin, Mawuena Binka, Niamh Caffrey, Steven J Drews

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Perceptions of donor screening-Do I always need to tell the truth?Transfusion medicine (Oxford, England) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Sheila F O'BrienEpidemiology and Surveillance, Canadian Blood Services, Ottawa, ON K1G 4J5, Canada.ORCID 0000-0002-5332-2789
Cassandra N ReedmanEpidemiology and Surveillance, Canadian Blood Services, Ottawa, ON K1G 4J5, Canada.ORCID 0000-0003-3904-0993
Carla OsiowyNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3P6, Canada.
Shelly BolotinCenter for Vaccine Preventable Disease, University of Toronto, Toronto, ON M5S, Canada.
Qi-Long YiEpidemiology and Surveillance, Canadian Blood Services, Ottawa, ON K1G 4J5, Canada.
Lillian LourençoPublic Health Agency of Canada, Ottawa, ON K1A 0K9, Canada.
Antoine LewinHéma-Québec, Montreal, QC H4R 2W7, Canada.
Mawuena BinkaBC Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
Niamh CaffreyEpidemiology and Surveillance, Canadian Blood Services, Ottawa, ON K1G 4J5, Canada.ORCID 0000-0003-3054-9144
Steven J DrewsMedical Microbiology Department, Canadian Blood Services, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0003-2519-1109
Public Health Agency of Canada · CAUniversity of Ottawa · CACanadian Blood Services · CAHéma-Québec · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B surveillance is essential to achieving Canada's goal of eliminating hepatitis B by 2030. Hepatitis B rates, association of infection with vaccine age-eligibility, and risk factors were analyzed among 1,401,603 first-time Canadian blood donors from 2005 to 2020. Donors were classified as having likely chronic or likely resolved/occult infections based on hepatitis B surface antigen, anti-hepatitis B core antigen, and hepatitis B nucleic acid test results. Likely chronically infected and control donors (ratio 1:4) participated in risk-factor interviews. The 2019 rate of likely chronic infection was 61.9 per 100,000 (95% CI 46.5-80.86) and 1449.5 per 100,000 for likely resolved/occult infections (95% CI 1370.7-1531.7). Likely chronic infections were higher in males (OR 3.2; 95% CI 2.7-3.7) and the vaccine-ineligible birth cohort (OR 1.9; 95% CI 1.6-2.2). The main risk factors were living with someone who had hepatitis (OR 12.5; 95% CI 5.2-30.0) and ethnic origin from a high-prevalence country (OR 8.4; 95% CI 5.9-11.9). Undiagnosed chronic hepatitis B may be more prevalent in Canada than currently determined by traditional passive hepatitis B reporting. Blood donor data can be useful in informing hepatitis B rates and evaluating vaccination programs in Canada.

Indexed as

Blood DonorsHepatitis BCanadaDonor SelectionHumansMalePersistent InfectionPublic Health Surveillanceblood donorschronic hepatitis Bvaccination

Identifiers

PMID36851623
PMCPMC9966614
OpenAlexW4318778368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.